The potential promise of machine learning in myelodysplastic syndrome
Authors:
- 16 November 2024
- journal article
- Published by Elsevier in Seminars in Hematology
- Vol. 62 (3) , 235-242
Abstract
No abstract availableKeywords
Funding Information
- International Foundation
- Aplastic Anemia and MDS International Foundation
This publication has 98 references indexed in Scilit:
- Multiparameter flow cytometry in the evaluation of myelodysplasia: Analytical issuesCytometry Part B: Clinical Cytometry, 2022
- Development and validation of a machine learning model to predict venous thromboembolism among hospitalized cancer patientsAsia-Pacific Journal of Oncology Nursing, 2022
- Applicability of probabilistic graphical models for early detection of SARS-CoV-2 reactive antibodies after SARS-CoV-2 vaccination in hematological patientsAnnals of Hematology, 2022
- Perspectives of Patients About Artificial Intelligence in Health CareJAMA Network Open, 2022
- Frequency and risk factors for thrombosis in acute myeloid leukemia and high-risk myelodysplastic syndromes treated with intensive chemotherapy: a two centers observational studyAnnals of Hematology, 2022
- Development and Validation of a Machine Learning Model to Estimate Bacterial Sepsis Among Immunocompromised Recipients of Stem Cell TransplantJAMA Network Open, 2021
- Exploring dyserythropoiesis in patients with myelodysplastic syndrome by imaging flow cytometry and machine‐learning assisted morphometricsCytometry Part B: Clinical Cytometry, 2020
- Acute myeloid leukemia and artificial intelligence, algorithms and new scoresBest Practice & Research Clinical Haematology, 2020
- Big Data and Machine Learning in Health CareJAMA, 2018
- Causes of death in 2877 patients with myelodysplastic syndromesAnnals of Hematology, 2016